Approval · Notice of Compliance 25019 · 2021
SUPEMTEK: Notice of Compliance 25019
Issued January 14, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25019
- Date
- January 14, 2021
- Company
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUPEMTEK | 02510936 | Cancelled Post Market |
Medicinal ingredients
- RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A(H1N1) 45 MCG per 0.5ML
- RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A(H3N2) 45 MCG per 0.5ML
- RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (YAMAGATA) 45 MCG per 0.5ML
- RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (VICTORIA) 45 MCG per 0.5ML